A Study to Determine the Effects of Activity by Ambulation in Hospital Premises versus Strict Protective Isolation on Quality of Life in Severely Neutropenic Cancer Patients during Hospitalization
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Jacksonville, Florida: 17-010255
Sponsor Protocol Number: 17-010255
About this study
The purpose of this study is to determine if allowing patients to ambulate in the hallways outside of their hospital room by relaxing the policy of strict protective isolation in neutropenic patients improves the quality of life, and if this increases the risk of infection among these patients during hospitalization.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.
- Patients ≥ 18 years old, undergoing aHSCT or receiving chemotherapy for AML/ALL with absolute neutrophil count (ANC) <500 cells/µL with an anticipated hospital stay of greater than 2 weeks.
- Active infection requiring antibiotics, fever any time during admission, patients requiring ICU admissions, patients admitted for reasons other than bone marrow transplant or induction chemotherapy for ALL/AML.
- Other important variables that will be measured:
- Admission diagnosis
- Baseline Performance Status (ECOG score) and body mass index
- Type of chemotherapy/conditioning regimen: reduced intensity/myeloablative
- Duration of severe neutropenia
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Prakash Vishnu, M.B.B.S.
Contact us for the latest status
Candice Baldeo M.B.B.S.
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available